Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors

被引：0

作者：

Yang, Yu-Nuo ^{[1
]}

Wang, Li-Sheng ^{[2
]}

Dang, Yan-Qi ^{[1
]}

Ji, Guang ^{[1
]}

机构：

[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, China Canada Ctr Res Digest Dis, 725 South Wanping Rd, Shanghai 200032, Peoples R China

[2] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2024年 / 30卷 / 32期

关键词：

Gastric cancer; Immune checkpoint inhibitors; Sarcopenia; Myosteatosis; Prediction model;

D O I：

10.3748/wjg.v30.i32.3726

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The emergence of immunotherapy, particularly immune checkpoint inhibitors (ICIs), represents a groundbreaking approach to treating gastric cancer (GC). However, the prognosis of GC patients receiving ICI treatment is influenced by various factors. This manuscript identified sarcopenia and myosteatosis as inde-pendent prognostic factors impacting the outcomes of GC patients treated with ICIs. Additionally, this study introduced a visual predictive model to estimate the prognosis of GC patients. If confirmed by further studies, this observation could provide valuable insights to propel the advancement of personalized clinical medicine and the integration of precision medicine practices.

引用

页数：5

共 50 条

[21] Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
Hao, Wen
Liu, Wenjing
Chang, Ruimin
Yang, Mi
Xin, Kai
Liu, Jingxin
Wang, Yibing
Ren, Meijin
Xie, Jiaqi
Yang, Yang
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
[22] Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients
Zhao, Yue
Ji, Zhengzheng
Li, Jiasong
Zhang, Shasha
Wu, Chensi
Zhang, Ruixing
Guo, Zhanjun
FRONTIERS IN ONCOLOGY, 2022, 12
[23] The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer
Kang, Da Hyun
Choi, Seong-woo
Sun, Pureum
Chung, Chaeuk
Park, Dongil
Lee, Song-, I
Koh, Jeong Suk
Kim, Yoonjoo
Lee, Jeong Eun
THORACIC CANCER, 2022, 13 (16) : 2346 - 2354
[24] Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy
Ma, Yingjie
Yu, Junxian
Ma, Xiaoting
Li, Qin
Su, Qiang
Cao, Bangwei
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (02) : 180 - 187
[25] Current status of immune checkpoint inhibitors for gastric cancer
Koji Kono
Shotaro Nakajima
Kosaku Mimura
Gastric Cancer, 2020, 23 : 565 - 578
[26] Current status of immune checkpoint inhibitors for gastric cancer
Kono, Koji
Nakajima, Shotaro
Mimura, Kosaku
GASTRIC CANCER, 2020, 23 (04) : 565 - 578
[27] Efficacy of immunotherapy (IT) after prior immune checkpoint inhibitors (ICIs) exposure
Hernando-Calvo, A.
Valdivia, A.
Santa Gadea, O. Saavedra
Brana, I.
Berche, R.
Matos, I.
Vieito, M.
Azaro Pedrazzoli, A. B.
Alonso Casal, G.
Galvao, V.
Diez Garcia, M.
Verdaguer, H.
Ortiz Velez, C.
Gonzalez, M.
Baraibar Argota, I.
Callejo, A.
Munoz Couselo, E.
Tabernero, J.
Dienstmann, R.
Garralda, E.
ANNALS OF ONCOLOGY, 2020, 31 : S489 - S490
[28] Combination of photosensitizer and immune checkpoint inhibitors for improving the efficacy of tumor immunotherapy
Li, Kexin
Yu, Huan
Bao, Zhihong
Xu, Lu
Zhang, Hong
Wang, Tian
Yu, Longyue
Yuan, Yue
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 629
[29] Efficacy and toxicity of immunotherapy with immune checkpoint inhibitors in gynecologic cancers.
Kuznicki, Michelle
Joehlin-Price, Amy
Rose, Peter Graham
Mahdi, Haider
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[30] Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy
Abdel-Wahab, Noha
Suarez-Almazor, Maria E.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (08) : 873 - 893

← 1 2 3 4 5 →